デフォルト表紙
市場調査レポート
商品コード
1404825

骨移植片と代替物の市場規模、シェア、動向分析レポート:材料タイプ別、用途別、地域別、セグメント予測、2024年~2030年

Bone Grafts And Substitutes Market Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Dental), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
骨移植片と代替物の市場規模、シェア、動向分析レポート:材料タイプ別、用途別、地域別、セグメント予測、2024年~2030年
出版日: 2023年11月30日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

骨移植片と代替物市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の骨移植片と代替物市場規模は、2024年から2030年にかけてCAGR 6.4%を記録し、2030年には45億4,000万米ドルに達すると予測されています。

整形外科疾患の有病率の増加と整形外科手術件数の急増が、市場成長の原動力となりそうです。加えて、高度な整形外科用移植片と代替物の開発における技術進歩や、高度な移植片に対する世界の需要の増加に対応するための大手企業による投資の増加が、業界の拡大をさらにエスカレートさせています。

副作用を軽減するための生体適合性骨移植片の開発需要の増加が市場を牽引しています。他と比較して優れた生体適合性を示すハイドロキシアパタイトやリン酸三カルシウムを用いた合成骨移植片の使用が増加していることが、市場の成長に拍車をかけています。市場開拓企業は、より優れた生体適合性、生物活性、適切な機械的特性を備えた新製品を継続的に開発しています。例えば、2020年10月、Graftysはオーストラリア、ブラジル、カナダ、米国において、同社の無菌リン酸カルシウム再吸収性骨空隙充填材および関連デリバリーシステムについて医療機器単一監査プログラム(MDSAP)認証を取得しました。

密度における骨移植片の使用の増加は、歯科用骨移植片と代替物市場の成長を促進しています。骨移植片は主に、骨形成を促進し治癒を促進するための足場や充填材として使用されます。歯科インプラント手術は現在、骨移植や骨再生などの高度な外科技術によって非常に普及しています。さらに、歯科インプラントの需要の増加と成功率が市場の成長を促進しています。米国インプラント歯科学会によると、2020年現在、歯科インプラントを受ける人の数は毎年50万人増加しています。また、この情報源は、インプラント歯科分野における95%の成功率を報告しています。米国では毎年約500万件のインプラント手術が行われています。

合成骨移植技術は先進医療に貢献しているが、そのコストは高く、市場の成長を抑制しています。DBMの平均価格は600~865米ドル、骨形成タンパク質マトリックスの平均価格は3,450~5,000米ドル、セラミック&ポリマー系合成骨移植片の平均価格は893~2,000米ドルです。さらに、使用する自家骨移植片や代用骨移植片によって償還方針が異なるため、処置のコストが高くなります。これは、切開やドナー移植片の入手困難の回避に役立ちます。そのため、関連機器や技術のコストが高いことが市場成長の妨げになる可能性があります。

骨移植片と代替物市場レポートハイライト

  • 材料タイプに基づくと、同種移植片セグメントは2023年に60.3%の最大の収益シェアを占め、予測期間中に大きな成長機会を示すと予測されています。同種移植片の採用は、骨伝導性、即時構造支持などの特性により著しく増加しています。合成分野では、予測期間中に最も急速な成長が見込まれます。
  • 用途別では、脊椎固定サブセグメントが2023年に最大の市場シェアを占めました。脊椎癒合術への骨移植材の採用が増加していること、多くの整形外科的疾患にかかりやすい老年人口が増加していることが、このセグメントの収益シェアを高めています。
  • 北米は、2023年に世界の骨移植片および代用品市場を独占し、予測期間中、主要な収益貢献者になると予測されています。老年人口の増加、スポーツ傷害や死亡事故の発生率の増加は、北米における骨移植片と代替物の需要を押し上げる主な要因の一つです。
  • 大手企業には、スミス・アンド・ネフュー、メドトロニック、デピュー・シンセなどがあり、予測期間中、製品普及、地域プレゼンス、収益、戦略的イニシアチブの面で市場での地位を維持しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 骨移植片と代替物の市場変数、動向および範囲

  • 規制の枠組み
  • USFDAの考慮事項
    • 医学的に必要であると認められた骨移植片と代替物
  • 償還の枠組み
    • CPTコーディング
    • HCPCSコーディング
    • 市場促進要因分析
    • 市場抑制要因分析
  • 骨移植片と代替物市場分析ツール:ポーター
  • PESTEL分析
  • 材料タイプ別の価格分析

第4章 骨移植片と代替物市場:競合分析

  • イノベーター
  • 主要企業の市場シェア分析、2021年(推定)
  • 市場リーダー
  • 製品セグメント別の市場リーダー
  • 主要取引と戦略的提携の分析
    • 製品の発売
    • 買収
    • 製品の承認
    • パートナーシップとコラボレーション
  • 非公開会社一覧

第5章 骨移植片と代替物市場:材料タイプの推定・動向分析

  • 材料タイプの市場シェア分析、2023年および2030年
  • マテリアルタイプダッシュボード
    • 同種移植片
    • 合成

第6章 骨移植片と代替物市場:用途の推定・動向分析

  • 用途市場シェア分析、2023年および2030年
  • 用途ダッシュボード
  • 頭蓋顎顔面
    • 頭蓋顎顔面市場推計・予測、2017年~2030年
  • 歯科
    • 歯科市場推計・予測、2017年~2030年
  • 足と足首
    • 足と足首の市場推計・予測、2017年~2030年
  • 関節再建
    • 関節再建市場推計・予測、2017年~2030年
  • 長骨
    • 長骨市場推計・予測、2017年~2030年
  • 脊椎固定術
    • 脊椎固定術市場推計・予測、2017年~2030年

第7章 骨移植片と代替物市場:新型コロナウイルス感染症の影響分析

  • 新型コロナウイルス感染症(COVID19)の蔓延分析
  • 機会分析

第8章 骨移植片と代替物市場:地域別の推定・動向分析、材料タイプ、用途別

  • 地域市場のスナップショット
  • 北米
    • 北米の骨移植片と代替物市場推計・予測、2017年~2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の骨移植片と代替物市場推計・予測、2017年~2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • ノルウェー
    • スウェーデン
  • アジア太平洋
    • アジア太平洋の骨移植片と代替物市場推計・予測、2017年~2030年
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ラテンアメリカの骨移植片と代替物市場推計・予測、2017年~2030年
    • メキシコ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの骨移植片と代替物市場推計・予測、2017年~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 企業プロファイル

  • AlloSource
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Baxter
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • DePuy Synthes
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Medtronic
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • NuVasive, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Orthofix Medical, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Smith+Nephew
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Stryker
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Biobank
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • OST Laboratories
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
  • Zimmer Biomet
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Geistlich Pharma AG
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • TBF
    • 会社概要
    • 製品のベンチマーク
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Primary interview details: North America
  • TABLE 3 Primary interview details: Europe
  • TABLE 4 Primary interview details: APAC
  • TABLE 5 Primary interview details: Latin America
  • TABLE 6 Primary interview details: MEA
  • TABLE 7 List of abbreviation
  • TABLE 8 Average cost of bone graft (2023)
  • TABLE 9 North America Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 10 North America Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 11 U.S. Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 12 U.S. Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 13 Canada Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 14 Canada Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 15 Europe Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 16 Europe Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 17 U.K. Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 18 U.K. Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 19 Germany Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 20 Germany Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 21 France Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 22 France Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 23 Italy Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 24 Italy Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 25 Spain Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 26 Spain Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 27 Denmark Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 28 Denmark Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 29 Norway Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 30 Norway Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 31 Sweden Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 32 Sweden Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 33 Asia Pacific Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 34 Asia Pacific Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 35 Japan Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 36 Japan Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 37 China Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 38 China Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 39 India Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 40 India Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 41 South Korea Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 42 South Korea Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 43 Australia Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 44 Australia Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 45 Latin America Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 46 Latin America Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 47 Brazil Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 48 Brazil Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 49 Mexico Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 50 Mexico Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 51 Argentina Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 52 Argentina Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 53 MEA Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 54 MEA Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 55 South Africa Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 56 South Africa Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 57 Saudi Arabia Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 58 Saudi Arabia Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 59 UAE Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 60 UAE Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 61 Kuwait Bone Graft & Substitutes market estimates and forecasts, by material type, 2017 - 2030 (USD million)
  • TABLE 62 Kuwait Bone Graft & Substitutes market estimates and forecasts, by application, 2017 - 2030 (USD million)
  • TABLE 63 Major merger & acquisitions
  • TABLE 64 List of key emerging companies
  • TABLE 65 List of key private companies
  • TABLE 66 List of Distributors

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Primary interviews in North America
  • FIG. 6 Primary interviews in Europe
  • FIG. 7 Primary interviews in Asia Pacific
  • FIG. 8 Primary interviews in Latin America
  • FIG. 9 Primary interviews in Middle East and Africa
  • FIG. 10 Market research approaches
  • FIG. 11 Value-chain-based sizing & forecasting
  • FIG. 12 QFD modeling for market share assessment
  • FIG. 13 Market formulation & validation
  • FIG. 14 Commodity flow analysis
  • FIG. 15 BGS market, 2017 - 2030 (USD Millions)
  • FIG. 16 Bone Grafts & Substitutes market snapshot
  • FIG. 17 Bone Grafts & Substitutes market driver impact
  • FIG. 18 Common Causes of Spinal Injury, 2018
  • FIG. 19 Age Distribution of Spinal Fusion Surgeries,2018
  • FIG. 20 Bone grafts & Substitutes market restraint impact
  • FIG. 21 Bone grafts & substitutes market Porter's five forces analysis
  • FIG. 22 Bone grafts & substitutes market PESTEL analysis
  • FIG. 23 Company market share analysis (Estimated)
  • FIG. 24 Market leader by product segment
  • FIG. 25 Strategy mapping
  • FIG. 26 Bone grafts & substitutes market: material type movement analysis
  • FIG. 27 Bone grafts & substitutes market material type dashboard
  • FIG. 28 Global allograft market, 2017 - 2030 (USD Million)
  • FIG. 29 Global demineralized bone matrix (DBM) market, 2017 - 2030 (USD Million)
  • FIG. 30 Global others market, 2017 - 2030 (USD Million)
  • FIG. 31 Global synthetic market, 2017 - 2030 (USD Million)
  • FIG. 32 Global Ceramic market, 2017 - 2030 (USD Million)
  • FIG. 33 Global HAP market, 2017 - 2030 (USD Million)
  • FIG. 34 Global B-TCP market, 2017 - 2030 (USD Million)
  • FIG. 35 Global α-TCP market, 2017 - 2030 (USD Million)
  • FIG. 36 Global bi-phasic calcium phosphates (BCP) market, 2017 - 2030 (USD Million)
  • FIG. 37 Global others market, 2017 - 2030 (USD Million)
  • FIG. 38 Global composite market, 2017 - 2030 (USD Million)
  • FIG. 39 Global polymers market, 2017 - 2030 (USD Million)
  • FIG. 40 Global BMP market, 2017 - 2030 (USD Million)
  • FIG. 41 Bone Grafts & Substitutes market: Application movement analysis
  • FIG. 42 Bone Grafts & Substitutes Application dashboard
  • FIG. 43 Global craniomaxillofacial market, 2017 - 2030 (USD Million)
  • FIG. 44 Global dental market, 2017 - 2030 (USD Million)
  • FIG. 45 Global foot & ankle market, 2017 - 2030 (USD Million)
  • FIG. 46 Global joint reconstruction market, 2017 - 2030 (USD Million)
  • FIG. 47 Global long bone market, 2017 - 2030 (USD Million)
  • FIG. 48 Global spinal fusion market, 2017 - 2030 (USD Million)
  • FIG. 49 Regional market place: Key takeaways
  • FIG. 50 Regional outlook, 2023 & 2030
  • FIG. 51 North America bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 52 U.S. bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 53 Canada bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 54 Europe bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 55 UK bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 56 Germany bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 57 France bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 58 Italy bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 59 Spain bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 60 Denmark bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 61 Norway bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 62 Sweden bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 63 Asia Pacific bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 64 China bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 65 Japan bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 66 India bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 67 South Korea bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 68 Australia bone graft and substitutes market, 2017 - 2030 (USD Million)
  • FIG. 69 Latin America bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 70 Mexico bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 71 Brazil bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 72 Argentina bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 73 MEA bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 74 South Africa bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 75 Saudi Arabia bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 76 UAE bone grafts & substitutes market, 2017 - 2030 (USD Million)
  • FIG. 77 Kuwait bone grafts & substitutes market, 2017 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-154-2

Bone Grafts And Substitutes Market Growth & Trends:

The global bone grafts and substitutes market size is anticipated to reach USD 4.54 billion by 2030, registering a CAGR of 6.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of orthopedic disorders and surge in number of orthopedic surgeries are likely to drive the market growth. In addition, technological advancements in developing advanced orthopedic grafts & substitutes and rising investments by leading players to meet increasing global demand for advanced grafts have further escalated the industry expansion.

Increasing demand for developing biocompatible bone grafts to reduce adverse reactions is driving the market. Increasing use of synthetic bone grafts with Hydroxyapatite and Tricalcium Phosphate, which has shown better biocompatibility as compared to others, is fueling the market growth. Market players are continuously developing new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in October 2020, Graftys received Medical Device Single Audit Program (MDSAP) certification for its Sterile Calcium Phosphate Resorbable Bone Void Fillers and related delivery systems in Australia, Brazil, Canada, and U.S. It also received CE recertification in Europe.

The increasing use of bone grafts in density is propelling the growth of dental bone grafts and substitutes market. The bone grafts are mostly used as a scaffold and filler to facilitate bone formation and promote healing. Dental implant surgery has now become very popular with advanced surgical techniques such as bone grafts and bone regeneration. Moreover, increasing demand and success rates of dental implants are fueling market growth. According to the American Academy of Implant Dentistry, as of 2020, the number of people getting dental implants has risen by 500,000 annually. The source also reported a success rate of 95% in the implant dentistry segment. Around 5 million implant procedures are performed in the U.S. every year.

Synthetic bone graft technology is benefiting advanced medicine, but the cost of such technologies is high, thus restraining market growth. The average price of DBM ranges from USD 600 to USD 865; that of bone morphogenetic protein matrix ranges from USD 3,450 to USD 5,000, and of synthetic ceramic & polymer-based bone grafts ranges from USD 893 to USD 2,000. In addition, reimbursement policies vary based on autografts and bone graft substitutes used, which increase the cost of procedures. This helps avoid incisions and difficulty in obtaining donor grafts. Therefore, the high cost of associated devices and technologies may hinder market growth.

Bone Grafts And Substitutes Market Report Highlights:

  • Based on material type, the allograft segment held the largest revenue share of 60.3% in 2023 and is anticipated to witness significant growth opportunities during the forecast period. The allograft adoption is significantly increasing owing to its properties such as osteoconductivity, and immediate structural support. The synthetic segment is projected to exhibit the fastest growth over the forecast period
  • Based on application, the spinal fusion sub-segment held the largest market share in 2023. The increasing adoption of bone graft materials for spondylosyndesis and rising geriatric population prone to a number of orthopedic ailments are responsible for the higher revenue share of the segment
  • North America dominated the global bone grafts and substitutes market in 2023 and is projected to be the leading revenue contributor during the forecast period. The rising geriatric population and increasing incidence of sports injuries & fatal accidents are among the key factors boosting the demand for bone grafts and substitutes in North America
  • Some of the leading players include Smith & Nephew, Medtronic, and DePuy Synthes, as they have maintained their market position during the forecast period in terms of product penetration, regional presence, revenue, as well as strategic initiatives

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Latin America
      • 1.3.5.5 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Abbreviations
  • 1.10 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Market Outlook
    • 2.1.1 Bone Grafts & Substitutes market Outlook, 2017 - 2030 (USD Million)
  • 2.2 Bone Grafts & Substitutes Market Summary, 2023

Chapter 3 Bone Grafts & Substitutes Market Variables, Trends & Scope

  • 3.1 Regulatory Framework
  • 3.2 USFDA Consideration
    • 3.2.1 Bone grafts & substitutes that found to be medically necessary
  • 3.3 Reimbursement framework
    • 3.3.1 CPT Coding
    • 3.3.2 HCPCS Coding
    • 3.3.3 Market driver analysis
      • 3.3.3.1 Rising incidence of bone & joint disorders
      • 3.3.3.2 Advent of biocompatible synthetic graft
      • 3.3.3.3 Rising demand for dental bone grafts
      • 3.3.3.4 Technological advancement
      • 3.3.3.5 Rising geriatric population
    • 3.3.4 Market restraint analysis
      • 3.3.4.1 Stringent regulatory guidelines
      • 3.3.4.2 Risk of disease transmission
      • 3.3.4.3 High cost of bone grafts and substitutes
  • 3.4 Bone Grafts & Substitutes Market Analysis Tools: Porters
  • 3.5 PESTEL Analysis
  • 3.6 Estimated Market Volume, By Material Type, Global & Regional, 2017 - 2030
  • 3.7 Pricing Analysis, By Material Type

Chapter 4 Bone Grafts & Substitutes Market: Competitive Analysis

  • 4.1 Innovators
  • 4.2 Key Company Market Share Analysis, 2021 (Estimated)
  • 4.3 Market Leaders
  • 4.4 Market Leaders by Product Segment
  • 4.5 Major Deals & Strategic Alliances Analysis
    • 4.5.1 Product launch
    • 4.5.2 Acquisitions
    • 4.5.3 Product Approval
    • 4.5.4 Partnership & Collaborations
  • 4.6 List of private companies

Chapter 5 Bone Grafts & Substitutes Market: Material Type Estimates & Trend Analysis

  • 5.1 Material Type Market Share Analysis, 2023 & 2030
  • 5.2 Material Type Dashboard
    • 5.2.1 Allograft
      • 5.2.1.1 Allograft market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.1.2 Demineralized Bone Matrix (DBM)
      • 5.2.1.2.1 Demineralized Bone Matrix (DBM) market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.1.3 Others
      • 5.2.1.3.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.2.2 Synthetic
      • 5.2.2.1 Synthetic market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.2 Ceramic
      • 5.2.2.2.1 Ceramic market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.2.2 HAP
      • 5.2.2.2.2.1 HAP market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.2.3 B-TCP
      • 5.2.2.2.3.1 B-TCP market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.2.4 αlpha-tricalcium phosphate (αlpha-TCP)
      • 5.2.2.2.4.1 αlpha-TCP market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.2.5 Bi-phasic calcium phosphates (BCP)
      • 5.2.2.2.5.1 Bi-phasic calcium phosphates (BCP) market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.2.6 Others
      • 5.2.2.2.6.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.3 Composite
      • 5.2.2.3.1 Composite market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.4 Polymers
      • 5.2.2.4.1 Polymers market estimates and forecasts, 2017 - 2030 (USD Million)
      • 5.2.2.5 BMP
      • 5.2.2.5.1 BMP market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 6 Bone Grafts & Substitutes Market: Application Estimates & Trend Analysis

  • 6.1 Application Market Share Analysis, 2023 & 2030
  • 6.2 Application Dashboard
  • 6.3 Craniomaxillofacial
    • 6.3.1 Craniomaxillofacial market estimates and forecasts, 2017 - 2030 (USD Million)
  • 6.4 Dental
    • 6.4.1 Dental market estimates and forecasts, 2017 - 2030 (USD Million)
  • 6.5 Foot & Ankle
    • 6.5.1 Foot & Ankle market estimates and forecasts, 2017 - 2030 (USD Million)
  • 6.6 Joint Reconstruction
    • 6.6.1 Joint Reconstruction market estimates and forecasts, 2017 - 2030 (USD Million)
  • 6.7 Long Bone
    • 6.7.1 Long Bone market estimates and forecasts, 2017 - 2030 (USD Million)
  • 6.8 Spinal Fusion
    • 6.8.1 Spinal Fusion market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 7 Bone Grafts & Substitutes Market: COVID19 Impact Analysis

  • 7.1 COVID19 Prevalence Analysis
  • 7.2 Opportunity Analysis

Chapter 8 Bone Grafts & Substitutes Market: Regional Estimates & Trend Analysis, By, Material Type, & Application

  • 8.1 Regional Market Snapshot
  • 8.2 North America
    • 8.2.1 North America Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030(USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030(USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Bone Grafts & Substitutes MARKET estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 UK Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030(USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Germany Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Spain Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.3.7 Denmark
      • 8.3.7.1 Denmark Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.3.8 Norway
      • 8.3.8.1 Norway Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.3.9 Sweden
      • 8.3.9.1 Sweden Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.4.2 China
      • 8.4.2.1 China Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.4.3 Japan
      • 8.4.3.1 Japan Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.4.6.1 Australia Bone Graft and Substitutes market, 2017 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.2 Mexico
      • 8.5.2.1 Mexico Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.3 Brazil
      • 8.5.3.1 Brazil Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.4 Mexico
      • 8.5.4.1 Mexico Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.5 Argentina
      • 8.5.5.1 Argentina Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.6 MEA
    • 8.6.1 MEA Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.6.5 Kuwait
      • 8.6.5.1 Kuwait Bone Grafts & Substitutes market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 9 Company Profiles

  • 9.1 AlloSource
    • 9.1.1 Company overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product benchmarking
    • 9.1.4 Strategic Initiatives
  • 9.2 Baxter
    • 9.2.1 Company overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product benchmarking
    • 9.2.4 Strategic Initiatives
  • 9.3 DePuy Synthes
    • 9.3.1 Company overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product benchmarking
    • 9.3.4 Strategic Initiatives
  • 9.4 Medtronic
    • 9.4.1 Company overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product benchmarking
    • 9.4.4 Strategic Initiatives
  • 9.5 NuVasive, Inc.
    • 9.5.1 Company overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product benchmarking
    • 9.5.4 Strategic Initiatives
  • 9.6 Orthofix Medical, Inc.
    • 9.6.1 Company overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product benchmarking
    • 9.6.4 Strategic Initiatives
  • 9.7 Smith + Nephew
    • 9.7.1 Company overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product benchmarking
    • 9.7.4 Strategic Initiatives
  • 9.8 Stryker
    • 9.8.1 Company overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product benchmarking
    • 9.8.4 Strategic Initiatives
  • 9.9 Biobank
    • 9.9.1 Company overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product benchmarking
    • 9.9.4 Strategic Initiatives
  • 9.10 OST Laboratories
    • 9.10.1 Company overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product benchmarking
  • 9.11 Zimmer Biomet
    • 9.11.1 Company overview
    • 9.11.2 Financial performance
    • 9.11.3 Product benchmarking
    • 9.11.4 Strategic initiatives
  • 9.12 Geistlich Pharma AG
    • 9.12.1 Company overview
    • 9.12.2 Financial performance
    • 9.12.3 Product benchmarking
    • 9.12.4 Strategic initiatives
  • 9.13 TBF
    • 9.13.1 Company overview
    • 9.13.2 Product benchmarking